STOCK TITAN

Boston Scientific to Participate in Bernstein's 39th Annual Strategic Decisions Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Boston Scientific Corporation will participate in Bernstein's 39th Annual Strategic Decisions Conference on May 31, 2023. Chairman and CEO Mike Mahoney will have a 50-minute Q&A session at 8:00 a.m. EDT. The webcast will be available on the Investor Relations section of the company's website.
Positive
  • Boston Scientific's participation in Bernstein's conference could generate positive investor interest and potentially boost stock price.
Negative
  • No negative takes identified.

MARLBOROUGH, Mass., May 15, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in Bernstein's 39th Annual Strategic Decisions Conference on Wednesday, May 31, 2023.

Mike Mahoney, chairman and chief executive officer, will participate in a 50-minute question-and-answer session with the host analyst at approximately 8:00 a.m. EDT. A live webcast of the session will be available on the Investor Relations section of the Boston Scientific website at investors.bostonscientific.com.

The replay of the webcast will be accessible at investors.bostonscientific.com beginning approximately one hour following the completion of each event.

About Boston Scientific
Boston Scientific transforms lives through innovative medical solutions that improve the health of patients around the world.  As a global medical technology leader for more than 40 years, we advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare. For more information, visit www.bostonscientific.com and connect on Twitter and Facebook.

CONTACTS         


Media:                   

Investors:

Kate Haranis           

Lauren Tengler

508-683-6585 (office)   

508-683-4479 (office)

Media Relations               

Investor Relations

Boston Scientific Corporation   

Boston Scientific Corporation

Kate.Haranis@bsci.com             

BSXInvestorRelations@bsci.com

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/boston-scientific-to-participate-in-bernsteins-39th-annual-strategic-decisions-conference-301824527.html

SOURCE Boston Scientific Corporation

FAQ

When will Boston Scientific participate in Bernstein's conference?

Boston Scientific will participate in Bernstein's 39th Annual Strategic Decisions Conference on May 31, 2023.

Who will be participating from Boston Scientific?

Chairman and CEO Mike Mahoney will be participating in a 50-minute Q&A session.

Where can the webcast of the session be accessed?

The webcast will be available on the Investor Relations section of Boston Scientific's website.

Could Boston Scientific's participation impact the stock price?

Boston Scientific's participation in the conference could generate positive investor interest and potentially boost the stock price.

Boston Scientific Corp.

NYSE:BSX

BSX Rankings

BSX Latest News

BSX Stock Data

106.14B
1.46B
0.19%
93.66%
0.85%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
MARLBOROUGH

About BSX

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments.